External Scientific Advisory Committees (ESAC)

  1. Each thematic research area will have an External Scientific Advisory Committee.
  2. The External Scientific Advisory Committees will be bodies providing support and general scientific advice for the Governing Body, made up of scientists of special international relevance in the field of health sciences who have been distinguished in their professional or scientific careers in line with the Consortium’s objectives.
  3. Each External Scientific Advisory Committee will be made up of a President, elected by the President of the Governing Body, after hearing the aforementioned Governing Body’s opinion, and at least four members, appointed by the Governing Body. 

    The duration of the President’s office will be four years, and be extendible. The other members shall be in office for an initial term of two years, later extendible for different periods of time. The members of each External Scientific Advisory Committee shall designate their vice-president and secretary from their members.

  4. The Committees shall meet at least once a year, similarly being able to be called by their President at his or her  own initiative or at the request of the number of members to be defined..
  5. The members of the External Scientific Advisory Committees shall carry out their work on an unpaid basis with no prejudice to their right to be refunded for any duly substantiated expenses meant for them by the post and the per diems to which they are entitled in exercising their duties, in the terms laid down in State legislation, represented by Royal Decree 462/2002,  of 24th May, on compensation for service.

Functions of the External Scientific Advisory Committee in their thematic research area in the CIBER:

  1. The External Scientific Advisory Committee for each of the thematic areas of research shall inform and advise the Governing Body on the characteristics of the scientific and technical research in the national and international domains and on their possible effects on the operation of the CIBER.
  2. It shall also carry out the following functions:
    1. Advising with regard to the directives of scientific policy and institutional relations to be implemented by the CIBER.
    2. To examine and report on the proposal of the Strategic Plan, the proposals of Annual Scientific Reports and of the Annual Action Plans.
    3. To report on the suitability of programmes, resources and capacities for the purposes of the consortium.
    4. To advise on the strategy for transfer of results of the research.
    5. To advise on the policy of incorporating scientific personnel.
    6. To inform on the creation of research programmes.

Members of the External Scientific Advisory Committee:

Abhay Pandit Centre for Research in Medical Devices (CÚRAM) National University of Ireland - Galway, Irlanda
Olaf Dössel Karlsruhe Institute of Technology
Thomas Penzel Interdisciplinary Center of Sleep Medicine Charité, Berlin, Germany
Martijn van Griensven University of Maastricht, The Netherlands
Luisa de Cola Istituto di Ricerche Farmacologiche Mario Negri, Università di Milano
Jürgen Borlak Hannover Medical School
Begoña Castro Directora Científica de Histocell
João Mano, Universidad de Minho
Claus Michael Lehr Helmholtz Center for Infection Research (HZI), Saarland University, Germany
Joan Bigorra Director de Innovación del Hospital Clinic de Barcelona
Pilar Calvo PHARMAMAR, España

Harriet Wallberg, Instituto Karolinska, Solna, (Suecia)
Sally M. Marshall Universidad de Newcastle, Newcastle, (UK)
Timo Otonkoski Universidad de Helsinki, Helsinki, (Finlandia)
Decio Eizirik Universidad Libre, Bruselas (Bélgica)
Antonio Vidal-Puig Universidad de Cambridge, Cambridge (UK)
Ele Ferrannini Universidad de Pisa, Pisa (Italia)
Guadalupe García-Tsao Presidenta. University of Yale
Michael Trauner Vocal. University of Vienna
Alberto Sánchez-Fueyo Vocal. King´s College London
Massimo Colombo Vocal. University of Milán
Jan Tack Vocal. University of Leuven

Dr. Josep Torrent Farnell

Servicio de Farmacología Clínica Hospital de Sant Pau, UAB, Plataforma MM-ICS.

Dr. Augusto Rojas

Instituto Tecnológico y de Estudios Superiores de Monterrey. México
Dr. Reiner A Veitia

Universidad Paris Diderot. Francia.

Dr. Jorge di Paola Children´s Hospital Colorado, Universidad del Colorado, USA.
Dr. Julián Isla Fundación Dravet, España
Dra. Alba Ancochea Federación Española de Enfermedades Raras (FEDER), España

Dr. David Gozal President. Univ. Missouri, Columbia, USA
Prof. Francesco Blasi Univ. Milano.
Prof. Antonio Anzueto Member. Texas, USA
Prof. Kenneth BM Reid Member. Univ. Oxford, United Kingdon
Prof. Michael S. Niederman Member. New York, USA
Prof. James R. Jett  Member. Minnesota, USA
Dr. Marc Humbert. Centre National de Référence de l'Hypertension Pulmonaire Sévère. París.
Prof. Bruno Crestaní.

Member. Univ. Paris Diderot.

Dr. Miguel Viveiros

Instituto de Higiene e Medicina Tropical Universidade NOVA de Lisboa

Henrique Barros University of Porto Medical School
Ana Navas Acién Columbia University
Javier Nieto Oregon State University
Jose María Valderas University of Exeter
Teymur Noori European Centre for Disease Prevention and Control
Ana Pilar Betrán Lázaga World Health Organization
María Gálvez Sierra Directora Gral. Plataforma de Organizaciones de Pacientes

Antonio Vidal-Puig University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science
Karine Clement Universidad de Paris
Geltrude Mingrone Catholic University of Rome
José M. Ordovás Professor Nutrition and Genetics JM-USDA-HNRCA at Tufts University
Lluis Fajas Research Director Metabolism and Cancer Laboratory - Montpellier - France
Serge Hercberg Universidad de Paris

Jim Van Os Universidad de Utrecht, Países Bajos.
Alessandro Zuddas. Universidad de Cagliari, Italia
Monica Di Luca. Universidad de Milán, Italia.

Til Wykes.

King’s College de Londres, Reino Unido.
Heinz Grunze Universidad de Salzburgo, Austria